World Journal of Stem Cells - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4689)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-16) series.

Item

Count

PDF

153

HTML

2478

Figures (1-3)

531

Tables (1-16)

440

Sum=3602

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

137

Download

702

Sum=839

Jun 26, 2024 (publication date) through Dec 9, 2025

Times Cited of This Article

Times Cited (10)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Kabatas S, Civelek E, Boyalı O, Sezen GB, Ozdemir O, Bahar-Ozdemir Y, Kaplan N, Savrunlu EC, Karaöz E. Safety and efficiency of Wharton’s Jelly-derived mesenchymal stem cell administration in patients with traumatic brain injury: First results of a phase I study. World J Stem Cells 2024; 16(6): 641-655 [PMID: 38948099 DOI: 10.4252/wjsc.v16.i6.641]
URL:	https://www.wjgnet.com/1948-0210/full/v16/i6/641.htm

Number	Citing Articles
1	Ningcen Li, Wenhui Lu, Limei Tang, Lina Zhu, Weibin Deng, Hang Liu, Changquan Huang, Jingying Jin, Jingjiao Zeng, Shitai Chen, Lianqi Geng, Xiuwu Hu, Liang Zhou. Microglia in Post‐Traumatic Brain Injury (TBI) Cognitive Impairment: From Pathological Changes to Therapeutic Approaches. CNS Neuroscience & Therapeutics 2025; 31(8) doi: 10.1111/cns.70568
2	Jun Beom Ku, Ray J. Pak, Sarah S. Ku, Robert D. Holland, Han-Soo Kim. Clinical Efficacy of Stem Cell Therapy in Neurotraumatic and Neurodegenerative Conditions: A Comparative Review. Tissue Engineering and Regenerative Medicine 2025; 22(8): 1051 doi: 10.1007/s13770-025-00757-2
3	Liem Thanh Nguyen, Giang Thi Huong Ha, Kien Trung Nguyen, Van Thanh Hoang, Quyen Thi Nguyen, Minh Van Pham, Anh Thi Phuong Nguyen, Doan Van Ngo, Huong Thu Le, Chi Van Nguyen. Autologous bone marrow mononuclear cell administration for neurological sequelae after traumatic brain injury: a matched control study. Brain Communications 2025; 7(5) doi: 10.1093/braincomms/fcaf361
4	Wangan Li, Xiangyu Wang, Zhiming Feng, Shiting Hua, Xiaoxiong Zou, Zelin Lai, Yingqian Cai, Yuxi Zou, Yanping Tang, Cai Lin, Guobiao Luo, Xiaolin Cai, Xiaodan Jiang. E2 pretreatment alleviates aggregation of intravenously injected mesenchymal stem cells in TBI by regulating BRG1 to affect adhesion. Stem Cell Research & Therapy 2025; 16(1) doi: 10.1186/s13287-025-04637-3
5	Jing Zhang, Yunqi Li, Penghui Ren, Mengna Jiang, Ping Wu, Qingping Wen. Efficacy and safety of intrathecal human umbilical cord-derived mesenchymal stromal cell therapy for bone cancer pain: a preclinical study. Stem Cell Research & Therapy 2025; doi: 10.1186/s13287-025-04820-6
6	Muzamil Akhtar, Abdulqadir J Nashwan. Evaluating Wharton’s jelly-derived stem cell therapy in autism: Insights from a case study. World Journal of Methodology 2025; 15(2): 100074 doi: 10.5662/wjm.v15.i2.100074 Abstract(741) \| Core Tip(742) \| Full Article(HTML)(2210) \| Full Article with Cover (PDF)-595K(119) \| Audio-576K(42) \| Peer-Review Report-182K(100) \| Answering Reviewers-51K(95) \| Full Article (PDF)-334K(138) \| Full Article (XML)-25K(108) \| Times Cited (0) \| Total Visits (5445) \| Open
7	Serdar Kabatas, Erdinç Civelek, Eyüp Can Savrunlu, Necati Kaplan, Tunç Akkoc, Nurten Küçükçakır, Mehmet Bozkurt, Erdal Karaöz. Efficacy and safety of exosomes from Wharton’s Jelly-derived mesenchymal stem cells in traumatic brain injury. World Journal of Critical Care Medicine 2025; 14(4): 103782 doi: 10.5492/wjccm.v14.i4.103782 Abstract(13) \| Core Tip(11) \| Full Article(HTML)(87) \| Full Article with Cover (PDF)-1682K(7) \| Audio-654K(8) \| Peer-Review Report-276K(9) \| Answering Reviewers-179K(7) \| Full Article (PDF)-1361K(22) \| Full Article (XML)-117K(6) \| Times Cited (0) \| Total Visits (369) \| Open
8	Qian Zhou, Wei Shen, Liang Wen. Advances in clinical neurorestorative treatments in brain trauma. Journal of Neurorestoratology 2025; 13(3): 100191 doi: 10.1016/j.jnrt.2025.100191
9	Tomasz Górnicki, Małgorzata Józkowiak, Krzysztof Data, Dominika Domagała, Julia Niebora, Ewa Okowińska, Anna Kłopot, Magdalena Kulus, Artur Bryja, Sławomir Woźniak, Adam Kamiński, Piotr Chmielewski, Aleksandra Górska, Aleksandra Partyńska, Teresa Wysocka, Marek Spaczyński, Hanna Piotrowska-Kempisty, Piotr Dzięgiel, Paul Mozdziak, Bogusław Czerny, Bartosz Kempisty. Wharton’s jelly mesenchymal stem cells (WJ-MSCs), a “Holy Grail” in tissue bioengineering and reconstructive medicine. Biomedicine & Pharmacotherapy 2025; 192: 118570 doi: 10.1016/j.biopha.2025.118570
10	P. R. Kamchatnov, O. Yu. Tsarapkina, N. G. Malyukova, A. V. Miretskaya, E. F. Danshina, L. A. Skipetrova, R. A. Cheremin. Treatment of post-traumatic cognitive disorders and asthenia: results of an observational study. Neurology, Neuropsychiatry, Psychosomatics 2024; 16(4): 14 doi: 10.14412/2074-2711-2024-4-14-20